Duncan F Brown

This inventor holds 33 USPTO granted patents and 20 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in RNA Interference Technology. Top assignees: Sirna Therapeutics, Inc., Case Venture Management, LLC, Merck Sharp + Dohme Corp.. Active years: 2003-2024.

USPTO Granted Patents = 33 (Patent Applications = 20)

% Patents Active = 72.7

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 3.7

ph-index = 13

Forward Citations = 1,860(Granted Patents)

Location History:

Grayslake, IL (US) (2003 - 2013)
Berkeley, CA (US) (2013 - 2024)

Company Filing History:

15 out of 140

Sirna Therapeutics, Inc.

patents

14 out of 15

Case Venture Management, LLC

patents

1 out of 2,405

Merck Sharp + Dohme Corp.

patents

4. 1 out of 5

Sima Therapeutics, Inc.

patents

5. 2 out of 834,453

Other

patents

Years Active: 2003-2024

Loading Chart...

Areas of Expertise:

RNA Interference

Gene Expression

Hepatitis B Virus

PHD2

Myostatin

CTNNB1

Short Interfering Nucleic Acids

Systemic Delivery

Nucleic Acid Inhibition

Lipophilic Moiety

Gene Therapy

Biotechnology

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11952573 - RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA) (2024-04-09),

2. 11529428 - Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety (2022-12-20),

3. 11332745 - RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (SINA) (2022-05-17),

4. 10793860 - RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (SINA) (2020-10-06),

5. 10729787 - Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety (2020-08-04),

6. 10577606 - RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA) (2020-03-03),

7. 10407682 - RNA interference mediated inhibition of hepatitis B Virus (HBV) gene expression using short interfering nucleic acid (siNA) (2019-09-10),

8. 10246714 - RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) (2019-04-02),

9. 10004814 - Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety (2018-06-26),

10. 9879262 - RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA) (2018-01-30),

11. 9850491 - RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) (2017-12-26),

12. 9464290 - RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA) (2016-10-11),

13. 9447420 - RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (SINA) (2016-09-20),

14. 9322020 - RNA interference mediated inhibition of isocitrate dehydrogenase (IDH1) gene expression (2016-04-26),

15. 9233997 - RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA) (2016-01-12),

Title: The Inventor Profile of Duncan F Brown

Introduction: Duncan F Brown, a talented inventor hailing from Grayslake, IL (US), has made significant contributions to the field of innovation with his creative mind and dedication to problem-solving.

Latest Patents: Duncan F Brown's latest patents showcase his expertise in developing cutting-edge solutions for everyday challenges. His most recent inventions focus on improving efficiency in household appliances and enhancing user experience in electronic devices.

Career Highlights: With a career spanning over two decades, Duncan F Brown has established himself as a prominent figure in the world of inventors. His innovative approach and attention to detail have led to the successful development of numerous patented technologies that have revolutionized various industries.

Collaborations: Throughout his career, Duncan F Brown has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His partnerships have been instrumental in turning his groundbreaking ideas into tangible products that have had a lasting impact on society.

Conclusion: Duncan F Brown's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His contributions to the field continue to inspire future generations of inventors to push the boundaries of what is possible.